All News
Avidin organized the fifth TAT-CF general assembly held in Budapest.
The famous Géllert Hotel was the venue selected for meeting. Thursday 14th was dedicated to a workshop session where all the partners presented the most
Lewis Acid-Catalyzed Diastereoselective Synthesis of Multisubstituted N-Acylaziridine-2-carboxamides from 2H-Azirines via Joullié–Ugi Three-Component Reaction
Lewis Acid-Catalyzed Diastereoselective Synthesis of Multisubstituted N-Acylaziridine-2-carboxamides from 2H-Azirines via Joullié–Ugi Three-Component Reaction (doi: 10.1021/acs.joc.7b03189) 3-9-2018 Avidin’s Medicinal Chemistry Department developed and established an innovative protocol
Our single cell protection buffer, the SingleCellProtectTM
Our single cell protection buffer, the SingleCellProtectTM was used in a recently published Nature Communication paper (doi:10.1038/s41467-017-02628-4) 3-4-2018 Previously we showed that single cells collected
Avidin joined to fourth cystic fibrosis consortium (H2020 TAT-CF) progress meeting in Mallorca (Spain)
Day one was dedicated to the 3rd TAT-CF workshop in which researchers from all partners presented their work within the H2020 project (Novel therapeutic approaches for
Recent Press release announced Hungarian companies can make a breakthrough in combating Alzheimer’s disease
The fruitful collaboration of AVIDIN Ltd. and SONEAS Research Ltd. working in the field of drug development has produced outstanding results from professional and also
Avidin’s chemistry R&D unit divided into new Divisions
Avidin’s chemistry R&D unit responsible for chemical synthesis and development was divided into two Divisions: Medicinal Chemistry Department lead by Iván Kanizsai, PhD and Organic
Avidin participated in cystic fibrosis consortium meeting
Avidin awarded with innovative, European Union grant to promote flexible work schedule
Poster in the 13th International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders
Avidin is presenting a poster in collaboration with Sanders-Brown Center on Aging, University of Kentucky at the AD/PDTM 2017 meeting, the 13th International Conference on